Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1959 1
1967 1
1969 1
1989 1
1990 1
1997 1
2000 1
2004 1
2005 1
2011 1
2012 2
2013 1
2014 3
2015 3
2016 3
2017 3
2018 2
2019 3
2021 2
2022 3
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial.
Westin SN, Moore K, Chon HS, Lee JY, Thomes Pepin J, Sundborg M, Shai A, de la Garza J, Nishio S, Gold MA, Wang K, McIntyre K, Tillmanns TD, Blank SV, Liu JH, McCollum M, Contreras Mejia F, Nishikawa T, Pennington K, Novak Z, De Melo AC, Sehouli J, Klasa-Mazurkiewicz D, Papadimitriou C, Gil-Martin M, Brasiuniene B, Donnelly C, Del Rosario PM, Liu X, Van Nieuwenhuysen E; DUO-E Investigators. Westin SN, et al. J Clin Oncol. 2024 Jan 20;42(3):283-299. doi: 10.1200/JCO.23.02132. Epub 2023 Oct 21. J Clin Oncol. 2024. PMID: 37864337 Free PMC article. Clinical Trial.
Efficacy and safety results by menopausal status in monarchE: adjuvant abemaciclib combined with endocrine therapy in patients with HR+, HER2-, node-positive, high-risk early breast cancer.
Paluch-Shimon S, Neven P, Huober J, Cicin I, Goetz MP, Shimizu C, Huang CS, Lueck HJ, Beith J, Tokunaga E, Contreras JR, de Sant'Ana RO, Wei R, Shahir A, Nabinger SC, Forrester T, Johnston SRD, Harbeck N. Paluch-Shimon S, et al. Among authors: contreras jr. Ther Adv Med Oncol. 2023 Feb 3;15:17588359231151840. doi: 10.1177/17588359231151840. eCollection 2023. Ther Adv Med Oncol. 2023. PMID: 36756142 Free PMC article.
Distinct oncogenic phenotypes in hematopoietic specific deletions of Trp53.
Palanichamy JK, Tran TM, King JK, Katzman S, Ritter AJ, Sharma G, Tso C, Contreras JR, Fernando TR, Sanford JR, Rao DS. Palanichamy JK, et al. Among authors: contreras jr. Sci Rep. 2023 May 9;13(1):7490. doi: 10.1038/s41598-023-33949-8. Sci Rep. 2023. PMID: 37160922 Free PMC article.
Group A streptococcal disease in paediatric inpatients: a European perspective.
Boeddha NP, Atkins L, de Groot R, Driessen G, Hazelzet J, Zenz W, Carrol ED, Anderson ST, Martinon-Torres F, Agyeman PKA, Galassini R, Herberg J, Levin M, Schlapbach LJ, Emonts M; EUCLIDS consortium. Boeddha NP, et al. Eur J Pediatr. 2023 Feb;182(2):697-706. doi: 10.1007/s00431-022-04718-y. Epub 2022 Nov 30. Eur J Pediatr. 2023. PMID: 36449079 Free PMC article.
Immunization with bacterial antigens: piscirickettsiosis.
Smith PA, Contreras JR, Larenas JJ, Aguillon JC, Garces LH, Perez B, Fryer JL. Smith PA, et al. Among authors: contreras jr. Dev Biol Stand. 1997;90:161-6. Dev Biol Stand. 1997. PMID: 9270845 Review.
Host gene expression signatures to identify infection type and organ dysfunction in children evaluated for sepsis: a multicentre cohort study.
Schlapbach LJ, Ganesamoorthy D, Wilson C, Raman S, George S, Snelling PJ, Phillips N, Irwin A, Sharp N, Le Marsney R, Chavan A, Hempenstall A, Bialasiewicz S, MacDonald AD, Grimwood K, Kling JC, McPherson SJ, Blumenthal A, Kaforou M, Levin M, Herberg JA, Gibbons KS, Coin LJM; EUCLIDS consortium; RAPIDS Study Group. Schlapbach LJ, et al. Lancet Child Adolesc Health. 2024 May;8(5):325-338. doi: 10.1016/S2352-4642(24)00017-8. Epub 2024 Mar 19. Lancet Child Adolesc Health. 2024. PMID: 38513681
Regulation of Marginal Zone B-Cell Differentiation by MicroRNA-146a.
King JK, Ung NM, Paing MH, Contreras JR, Alberti MO, Fernando TR, Zhang K, Pellegrini M, Rao DS. King JK, et al. Among authors: contreras jr. Front Immunol. 2017 Jan 16;7:670. doi: 10.3389/fimmu.2016.00670. eCollection 2016. Front Immunol. 2017. PMID: 28138326 Free PMC article.
38 results